JVMTX | VEVIX | JVMTX / VEVIX | |
Total Expense Ratio | 1.00 | 0.58 | 172% |
Annual Report Gross Expense Ratio | 1.11 | 0.58 | 191% |
Fund Existence | 12 years | 15 years | - |
Gain YTD | 8.361 | 2.176 | 384% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 2000000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 22.6B | 17.8B | 127% |
Annual Yield % from dividends | 0.65 | 1.16 | 56% |
Returns for 1 year | 3.31 | -1.55 | -213% |
Returns for 3 years | 23.47 | 9.56 | 245% |
Returns for 5 years | 61.96 | 48.84 | 127% |
Returns for 10 years | 46.97 | 51.23 | 92% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
EUFN | 31.77 | 0.21 | +0.67% |
iShares MSCI Europe Financials ETF | |||
XNOV | 35.66 | 0.19 | +0.52% |
FT Vest US Eq Enh & Mod Buf ETF-Nov | |||
JANW | 35.06 | 0.09 | +0.26% |
AllianzIM US Large Cap Buffer20 Jan ETF | |||
IAF | 4.51 | N/A | N/A |
abrdn Australia Equity Fund | |||
LIAT | 223.78 | N/A | N/A |
LifeX 2059 Infl-Prt Longevity Inc ETF |